First, we tested EdU incorporation of cancer cells in the presence of equal amount of Ly6G+CD11b+ cells, or at 2:1 and 4:1 ratio (Ly6G+CD11b+ cells vs. cancer cells). The gene discussed is ITGAM; the disease is cancer.